SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Large pharma companies at SNO 2026

Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website

7 large pharma companies are at SNO 2026 — 15 presentations on the program. Most represented: Jazz Pharmaceuticals (2 on the program), Servier (2 on the program), Alexion, AstraZeneca Rare Disease (1 on the program). 2 of them have their own page in this guide. As of Nov 12, 2026.

All 419 organizations at SNO 2026 →

Topic
Top represented
Showing 1–7 of 7 organizations
OrganizationSNO 2026 Attendance
Jazz Pharmaceuticals
Dublin, Ireland
◆Platinum Supporter
Large pharmaPlatinum Supporter
A biopharmaceutical company developing and marketing medicines, including therapies used in neuro-oncology.
Talk
Fri Nov 13
7–8:15am
Implementing Systemic Therapy in H3 K27-Altered DMG: Practical Strategies to Optimize Post-Radiation Care
Independence Ballroom, Level 3, Philadelphia Marriott Downtown
Therapeutics
Poster
Fri Nov 13
7:30–9:30pm
A phase 2 study to investigate the efficacy and safety of JZP3507 (formerly ONC206) in adults with recurrent grade 2 or 3 meningioma
Exhibit Hall D & E, Second Floor, Convention Center · Abstract TIP-12
Trials
Talk
Sat Nov 14
7–8:15am
Advances in Diagnosis and Treatment of H3 K27M-Mutant Diffuse Glioma
Liberty Ballroom ABC - Philadelphia Marriott Downtown
Therapeutics
Talk
Sat Nov 14
3:19–3:24pm
Session
Sat Nov 14
6–7pm
Servier
Suresnes, France
◆Platinum Supporter
Large pharmaPlatinum Supporter
An international pharmaceutical company developing and marketing medicines, including cancer therapies.
Talk
Fri Nov 13
7–8:15am
Clinical Crossroads of IDH-Mutant Glioma Care: Navigating Real-World Challenges and Complexities
Liberty Ballroom, Level 3, Philadelphia Marriott Downtown
Therapeutics
Poster
Fri Nov 13
7:30–9:30pm
One-year compliance to vorasidenib among patients with IDH-mutant glioma: real-world evidence from the GLIO-ADHERE study
Exhibit Hall D & E, Second Floor, Convention Center · Abstract INNV-27
Survivorship
Talk
Sat Nov 14
7–8:15am
◆Platinum Supporter
Large pharmaPlatinum Supporter
A biopharmaceutical company developing treatments for rare diseases, including therapies relevant to neurofibromatosis.
Talk
Fri Nov 13
7–8:15am
Treating NF1 plexiform neurofibromas in adult patients
115 C, First Floor, Convention Center
Rare tumors
Takeda
Tokyo, Japan
Large pharma
A global pharmaceutical company developing and marketing medicines, including treatments relevant to oncology.
Session
Thu Nov 12
8:40–10:50am
Daiichi Sankyo
Tokyo, Japan
◇Contributing Supporter
Large pharmaContributing Supporter
A global pharmaceutical company developing and marketing medicines, including oncology therapies.
Talk
Thu Nov 12
6–7:15pm
"Experts in the Hot Seat": Multidisciplinary Decision-making in Breast Cancer Brain Metastases in the ADC Era
Independence Ballroom, Level 3, Philadelphia Marriott Downtown
Metastases
AstraZeneca
Cambridge, UK
Large pharma
A global biopharmaceutical company whose medicines span oncology, rare disease, respiratory and cardiovascular care.
Talk
Thu Nov 12
6–7:15pm
"Experts in the Hot Seat": Multidisciplinary Decision-making in Breast Cancer Brain Metastases in the ADC Era
Independence Ballroom, Level 3, Philadelphia Marriott Downtown
Metastases
Medexus Pharma
Toronto, Canada
◇Contributing Supporter
Large pharmaContributing Supporter
A pharmaceutical company that develops and commercializes specialty medicines, including treatments relevant to oncology.
Sponsor
In the meeting’s sponsor directory, with no session on the public program

Explore the full SNO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Philadelphia. Leave your work email and we’ll be in touch.

Privacy

Download the full SNO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from large pharma companies

Tell us what you sell and we’ll find the people at these large pharma companies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse SNO 2026 by

Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction